Three months’ clinical outcomes from a nationwide non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis. Results from the DANBIO registry

B. Glintborg, Inge Juul Sørensen, Dorte Vendelbo Jensen, N S Krogh, A.G. Loft, A Colic, J. Espesen, J. Olsen, O. Hendricks, J Grydehøj, Inger Marie Jensen Hansen, M. V. Sørensen, Stavros Chrysidis, A. Linauskas, H M Lindegaard, B L Andersen, N. Manilo, M Klarlund, L S Andersen, H. NordinS. Kristensen, Merete Lund Hetland

OriginalsprogEngelsk
ArtikelnummerOP07
TidsskriftScandinavian Journal of Rheumatology
Vol/bind45
Udgave nummersup128
ISSN0300-9742
DOI
StatusUdgivet - 10 aug. 2016

Citationsformater